Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 593-599

  Cho, Kyu Hyang ^a   Do, Jun Young ^a   Park, Jong Won ^a   Yoon, Kyung Woo ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Fat accumulation; Icodextrin; Peritoneal dialysis (PD)

Indexed keywords

DIALYSIS FLUID; ICODEXTRIN;

ADULT; ARTICLE; BODY FAT; BODY MASS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; EXTRACELLULAR FLUID; FEMALE; GLUCOSE ABSORPTION; HUMAN; KIDNEY FAILURE; LEAN BODY WEIGHT; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TOTAL BODY WATER; WAIST HIP RATIO; WEIGHT GAIN;

ADULT; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; TIME FACTORS;

EID: 75649085660     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp473     Document Type: Article

References (30)

1. Stenvinkel P, Lindholm B, Lönnqvist F. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000; 11: 1303-1309
2. Fernström A, Hylander B, Moritz A et al. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18: 166-171
3. Soreide R, Dracup B, Svarstad E et al. Increased total body fat during PD treatment. Adv Perit Dial 1992; 8: 173-176
4. Axelsson J, Heimburger O, Lindholm B et al. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005;15: 131-136
5. Heimbürger O, Lindholm B, Bergström J. Nutritional effects and management of chronic peritoneal dialysis. In: Kopple JD, Massry D (eds).Nutritional Management of Renal Disease. Baltimore: Williams and Wilkins, 1997, 619-668
6. Gokal R, Moberly J, Lindholm B et al. Metabolic and laboratory effects of icodextrin. Kidney Int 2002; 62(Suppl 81): S62-S71
7. Frampton JE, Plosker GL. Icodextrin: a review of its use in peritoneal dialysis. Drugs 2003; 63: 2079-2105
8. Mujais S, Nolph K, Gokal R et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 4): S5-S21
9. Watson PE, Watson ID, Bratt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39
10. Bergström J, Heimbürger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance: what formulas should be used? Perit Dial Int 1998; 18: 467-473
11. Fleischmann E, Teal N, Dudley J et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-1567
12. Hakim RM, Lowrie E. Obesity and mortality in ESRD: is it good to be fat? Kidney Int 1999; 55: 1580
13. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554
14. Kalantar-Zadeh K, Kuwae N, Wu DY et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am j Clin Nutr 2006; 83: 202-210
15. Aslam N, Bernardini J, Fried L et al. Large body mass index dose not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 2002; 22: 191-196
16. Fried L, Bernardini J, Piraino B. Neither size nor weight predicts survival in peritoneal dialysis patients. Perit Dial Int 1996; 16: 357-361
17. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65: 597-605
18. Mcdonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003; 14: 2894-2901
19. Schmidt D, Salahudeen A. Obesity-survival paradox-still a controversy? Semin Dial 2007; 20: 486-492
20. Salahudeen A. Obesity and survival on dialysis. Am J Kidney Dis 2003; 41: 925-932
21. Heimbürger O, Lönnqvist F, Danielsson A et al. Serum immunore-active leptin concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423-1430 (Pubitemid 27491233)
22. Johansson A, Samuelsson O, Haraldsson B et al. Body composition in patients treated with peritoneal dialysis. Nephrol Dial Transplant 1998; 13: 1511-1517 (Pubitemid 28254329)
23. Grodstein GP, Blumenkrantz MJ, Kopple JD et al. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981; 19: 564-567
24. Heimbürger O, Waniewski J, Werynski A et al. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320-1332
25. Desanto NG, Capodicasa G, Senatore R et al. Glucose utilization from dialysate in patients on CAPD. Int J Artif Organs 1979; 2: 119-125
26. Mistry CD, Gokal R, Peers E: MIDAS study group: a randomized multicenter clinical trial comparing isosmolar icodextrin with hy-perosmolar glucose solution in CAPD. Kidney int 1994; 46: 496-503
27. Wolfson M, Piraino B, Hamburger RJ et al. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40: 1055-1065
28. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves the fluid states of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-2344
29. Heimbürger O. Obesity on PD patients: causes and management. Contrib Nephrol 2000; 140: 91-97
30. Wang X, Axelsson J, Nordfors L et al. Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 axon 8 insertion/deletion polymorphism. Nephrol Dial Transplant 2007; 22: 196-202